These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6185289)

  • 1. Oral tripotassium-dicitratobismuthate in gastric and duodenal ulceration. A double-blind controlled trial.
    Glover SC; Cantlay JS; Weir J; Mowat NA
    Dig Dis Sci; 1983 Jan; 28(1):13-7. PubMed ID: 6185289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased healing of gastric and duodenal ulcers in a controlled trial using tripotassium dicitrato-bismuthate.
    Lee SP; Nicholson GI
    Med J Aust; 1977 May; 1(22):808-12. PubMed ID: 329077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate.
    Martin DF; Hollanders D; May SJ; Ravenscroft MM; Tweedle DE; Miller JP
    Lancet; 1981 Jan; 1(8210):7-10. PubMed ID: 6109102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bicitropeptide, antacid and placebo in gastric and duodenal ulceration. A two-centre, double-blind, comparative endoscopic study.
    Mekel RC; Serfontein WJ; Bank S; Barbezat GO; Novis BH
    S Afr Med J; 1979 Jan; 55(2):43-6. PubMed ID: 371034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric ulcer healing with tripotassium dicitrato bismuthate and subsequent relapse.
    Sutton DR
    Gut; 1982 Jul; 23(7):621-4. PubMed ID: 7044913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colloidal bismuth subcitrate tablets and placebo in chronic duodenal ulceration: a double-blind, randomised trial.
    Wilson P; Alp MH
    Med J Aust; 1982 Mar; 1(5):222-3. PubMed ID: 7045603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tripotassium dicitrato-bismuthate tablets v liquid in the treatment of duodenal ulcers.
    Lane M; Lee S; Tasman-Jones C; Nicholson G
    N Z Med J; 1985 Mar; 98(775):191-2. PubMed ID: 3885084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twice daily tripotassium dicitrato bismuthate in the treatment of duodenal ulceration.
    Hollanders D
    Postgrad Med J; 1986 Jan; 62(723):19-21. PubMed ID: 3540918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer.
    Hamilton I; Worsley BW; O'Connor HJ; Axon AT
    Gut; 1983 Dec; 24(12):1148-51. PubMed ID: 6357964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers.
    Shreeve DR; Klass HJ; Jones PE
    Digestion; 1983; 28(2):96-101. PubMed ID: 6360774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised crossover trial of tripotassium dicitrato bismuthate versus high dose cimetidine for duodenal ulcers resistant to standard dose of cimetidine.
    Lam SK; Lee NW; Koo J; Hui WM; Fok KH; Ng M
    Gut; 1984 Jul; 25(7):703-6. PubMed ID: 6376292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparison of tripotassium dicitratobismuthate and cimetidine in the treatment of gastric ulcer].
    Chen SP; Pan GZ
    Zhonghua Nei Ke Za Zhi; 1986 Aug; 25(8):456-7, 509. PubMed ID: 3803058
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled clinical trial with De-Nol (tripotassium dicitrato bismuthate) in patients with gastric ulcer.
    Patty I; Deák G; Jávor T; Mózsik G; Nagy L; Tárnok F
    Int J Tissue React; 1983; 5(4):397-401. PubMed ID: 6368445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ranitidine in the treatment of gastric, prepyloric and duodenal ulcer--a controlled prospective double-blind trial.
    Darle N; Almskog B; Falk A; Fredriksen B; Gamklou R; Ivarsson L; Karlström L
    Ann Clin Res; 1984; 16(1):6-9. PubMed ID: 6331270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptic ulcer therapy with cimetidine versus tripotassium dicitrato bismuthate in rheumatoid arthritis patients undergoing chronic NSAID treatment.
    Bianchi Porro G; Lazzaroni M; Petrillo M; Ardizzone S; Manzionna G; Caruso I; Montrone F
    Aliment Pharmacol Ther; 1998 Apr; 12(4):343-7. PubMed ID: 9690723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic evaluation of the effect of Ulcerone and placebo on duodenal ulcers.
    Moshal MG
    S Afr Med J; 1976 May; 50(21):801-2. PubMed ID: 779056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirenzepine (LS 519) in severe duodenal ulcer and in gastric ulcer. A double-blind clinical trial.
    Oselladore D; Chierichetti SM; Norberto L; Vibelli C
    Scand J Gastroenterol Suppl; 1979; 57():33-9. PubMed ID: 396655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tri-potassium di-citrato bismuthate: a report of its pharmacological properties and therapeutic efficacy in peptic ulcer.
    Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976 Dec; 12(6):401-11. PubMed ID: 1001219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective coating of gastric ulcer by tripotassium dicitrato bismuthate in the rat.
    Koo J; Ho J; Lam SK; Wong J; Ong GB
    Gastroenterology; 1982 May; 82(5 Pt 1):864-70. PubMed ID: 7060908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ranitidine in the treatment of peptic ulcer.
    Makalinao AU; Zaño FM
    Clin Ther; 1984; 6(2):185-92. PubMed ID: 6322992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.